Standout Papers

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, an... 2019 2026 2021 2023 331
  1. Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies (2019)
    Gustavo Luna, Peter Alping et al. JAMA Neurology

Immediate Impact

11 by Nobel laureates 23 from Science/Nature 81 standout
Sub-graph 1 of 19

Citing Papers

The NLR family of innate immune and cell death sensors
2024 Standout
Multiple sclerosis
2023 Standout
4 intermediate papers

Works of Jan Hillert being referenced

Effect of Smoking Cessation on Multiple Sclerosis Prognosis
2015
MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction
2005
and 1 more

Author Peers

Author Last Decade Papers Cites
Jan Hillert 8475 4760 2380 2467 363 14.3k
Stephen L. Hauser 8163 5797 2309 3492 268 16.3k
Tanuja Chitnis 10666 3748 2244 2467 355 16.8k
Bruce Cree 8026 2658 1727 3079 275 12.5k
Peter Rieckmann 6616 3060 2308 2168 261 12.8k
D. A. S. Compston 7573 3467 1921 2226 179 13.3k
Alasdair Coles 8899 3735 2679 1898 193 13.1k
Jorge R. Oksenberg 6045 7661 2396 3928 239 16.5k
Krzysztof Selmaj 9341 5341 3209 4429 334 17.3k
Robert J. Fox 7728 2525 2166 2199 307 12.4k
Emmanuelle Waubant 14895 4026 2839 3222 221 20.4k

All Works

Loading papers...

Rankless by CCL
2026